Science & Technology
A new platform for inexpensive and scalable recombinant protein and growth factor production to support cell culture applications in therapeutics.
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R43GM146560-01A1
Award Ceiling
$324K
Award Floor
$324K
Close Date
Sep 19, 2025
Total Funding
$324K
Expected Awards
1
Posted Date
Sep 20, 2024
Cost Sharing Required
No
Grants.gov ID
sbir-1R43GM146560-01A1
Description
SBIR Phase Phase I award: "A new platform for inexpensive and scalable recombinant protein and growth factor production to support cell culture applications in therapeutics." awarded to OPERA BIOSCIENCE, INC. in EVANSTON, Illinois. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $323,644. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, Women-owned businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.